Prevention & Chronic Conditions


Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Related Articles


Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes

Chris Wai Hang Lo, Yue Fei, Bernard Man Yung Cheung,


Citation: Cardiac Failure Review 2021;7:e04.

Bridging the Gap in a Rare Cause of Angina

Sumanth Khadke, Jovana Vidovic, Vinod Patel,


Citation: European Cardiology Review 2021;16:e05.

Pharmacotherapy in Stable CAD: The ISCHEMIA Trial

Jonathan Yap, Derek P Chew, Gregg Stone,


Citation: European Cardiology Review 2021;16:e04.

Redefining the Standard for Atrial Fibrillation: A Patient-centric Report

Carina Blomström-Lundqvist, Helmut Pürerfellner, Alex White,


Citation: European Cardiovascular Review 2021;16(Suppl 1):1–6.